All News

Individuals with a history of Plasmodium falciparum protozoan parasitic infection had a significantly increased long-term risk of developing heart failure but not myocardial infarction or cardiovascular or all-cause death.

The study, according to the researchers, is the first to demonstrate the potential use of major histocompatibility complex class II (MHC-II) expression as a predictor of immunotherapy response in these patients.

Neal Dave, PharmD, the executive director of pharmacy at Texas Oncology, talks about the importance of conducting regular evaluations to ensure that prescribing the most cost-effective option, whether that be a biosimilar or the reference product.

According to researchers, the prevalence of progressive supranuclear palsy (PSP) identified by their study is consistent with, but on the lower end, of previously reported estimates.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

FDA is expected to recommend a plan on distribution of COVID-19 booster shots to immunocompromised Americans; California becomes the first state to issue a vaccine mandate for its health care workers; exploring the threat of COVID-19 infection in pediatric populations.

Taiwanese patients with uveitis were shown to be at greater risk of developing psoriasis and psoriatic arthritis than the general population, and hypertension, diabetes, and obesity were more prominent in these populations as well.

Regular use of selective serotonin reuptake inhibitors or tricyclic or tetracyclic antidepressants was associated with a reduced risk of all-cause mortality in patients with diabetes.

Researchers were able to use a next-generation sequencing assay to not only monitor minimal residual disease (MRD), but also to confirm diagnosis of cutaneous T-cell lymphoma, which can present as more benign conditions early on.

Patients with concurrent fatty liver disease and chronic hepatitis B exhibited higher cumulative rates of hepatitis B surface antigen seroclearance and lower cumulative rates of cirrhosis and hepatocellular carcinoma (HCC) across a 10-year period.

This recent study compared orthostatic hypotension outcomes among 2 patient populations, both with chronic kidney disease (CKD), who were or were not living with diabetic nephropathy (DNP).

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Study results indicate abnormalities in the vestibular cortical network may help researchers understand the underlying mechanisms of vestibular migraine.

The Biden administration looks into requiring foreign visitors to be fully vaccinated against COVID-19; subsidies generated from the American Rescue Plan led to savings on premiums for coverage through the Affordable Care Act (ACA); a federal review is under way on the controversial approval of the Alzheimer drug aducanumab (Aduhelm).

Collaborating with colleagues outside of dermatology helps to maximize the chances of skin cancer not coming back, especially in rare cases of noncontiguous tumors, noted Rajiv Nijhawan, MD, director of the UTSW High Risk Skin Cancer Transplant Clinic, in Dallas, Texas.

In one of the first studies to examine real-world evidence on rituximab biosimilars in the United States, investigators found that many providers treating patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) are regularly prescribing a biosimilar rituximab.

Hilary Babcock, MD, MPH, infectious disease specialist at Washington University and BJC Healthcare in St. Louis, Missouri, discusses the effectiveness of COVID-19 vaccination against the delta variant and the low likelihood of breakthrough infection.

Using artificial intelligence (AI) effectively may help to revolutionize the diagnosis, monitoring, and treatment of multiple sclerosis (MS), as well as optimizing understanding of the immune-mediated disease.

Treatment-related modifications have resulted in improved long-term outcomes for all adolescent and young adult (AYA) survivors of Hodgkin lymphoma, but new research highlights that racial, ethnic, and socioeconomic status disparities persist in the long term.

SisterLove Inc is a 32-year-old sexual reproductive health rights and justice organization with a core focus on HIV and sexually transmitted infections at the intersection of other challenges to women's sexual reproductive health and well-being.

The combined toll of the COVID-19 pandemic and the health effects of climate change tests an already beleaguered US health system.

A new report finds roughly three-quarters of patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis used painkillers, although biologics appear to curb the need for nonsteroidal anti-inflammatory drugs, in particular.

FDA reportedly aims to fully approve Pfizer-BioNTech COVID-19 vaccine by early next month; Biogen’s Alzheimer drug sees little uptake; majority of Americans over 65 have received at least 1 dose of a COVID-19 vaccine.

The Association of Community Cancer Centers’ (ACCC’s) annual survey on immuno-oncology (IO) therapies highlighted major concerns among health care providers regarding financial impacts, education, and access to clinical trial data.

Investigators of a 3-year observational study identified independent risk factors for exacerbations related to chronic obstructive pulmonary disease (COPD) and successfully developed a novel risk score for COPD exacerbations.

August is National Psoriasis Awareness Month, and on this episode of Managed Care Cast, we bring you an excerpt of an interview with a New Jersey dermatologist about the changing concept of psoriasis as more than just a skin disease.

The pandemic has exacerbated not only cardiovascular care, but also the mental health of patients, noted Mariana Garcia, MD, cardiology fellow in the Academic Clinical Investigator Pathway at Emory University and member of T32, Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health (METRIC).

Identifying patients with combined polypharmacy and frailty can help recognize ICU patients with high risk of hospital readmission, the authors said.